Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
Canada
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Parenteral
Topical
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
Market Place
ABOUT THIS PAGE
A Iloprost manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Iloprost, including repackagers and relabelers. The FDA regulates Iloprost manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Iloprost API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Iloprost manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Iloprost supplier is an individual or a company that provides Iloprost active pharmaceutical ingredient (API) or Iloprost finished formulations upon request. The Iloprost suppliers may include Iloprost API manufacturers, exporters, distributors and traders.
click here to find a list of Iloprost suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Iloprost DMF (Drug Master File) is a document detailing the whole manufacturing process of Iloprost active pharmaceutical ingredient (API) in detail. Different forms of Iloprost DMFs exist exist since differing nations have different regulations, such as Iloprost USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Iloprost DMF submitted to regulatory agencies in the US is known as a USDMF. Iloprost USDMF includes data on Iloprost's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Iloprost USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Iloprost suppliers with USDMF on PharmaCompass.
A Iloprost written confirmation (Iloprost WC) is an official document issued by a regulatory agency to a Iloprost manufacturer, verifying that the manufacturing facility of a Iloprost active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Iloprost APIs or Iloprost finished pharmaceutical products to another nation, regulatory agencies frequently require a Iloprost WC (written confirmation) as part of the regulatory process.
click here to find a list of Iloprost suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Iloprost as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Iloprost API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Iloprost as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Iloprost and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Iloprost NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Iloprost suppliers with NDC on PharmaCompass.
Iloprost Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Iloprost GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Iloprost GMP manufacturer or Iloprost GMP API supplier for your needs.
A Iloprost CoA (Certificate of Analysis) is a formal document that attests to Iloprost's compliance with Iloprost specifications and serves as a tool for batch-level quality control.
Iloprost CoA mostly includes findings from lab analyses of a specific batch. For each Iloprost CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Iloprost may be tested according to a variety of international standards, such as European Pharmacopoeia (Iloprost EP), Iloprost JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Iloprost USP).
LOOKING FOR A SUPPLIER?
